汤臣倍健(300146) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 reached ¥3,108,119,772.05, representing a 36.30% increase compared to ¥2,280,271,630.40 in the same period last year[3] - Net profit attributable to shareholders was ¥1,029,519,641.37, a 55.27% increase from ¥663,007,234.38 year-on-year[3] - The net profit excluding non-recurring gains and losses was ¥994,652,011.53, up 46.06% from ¥680,935,725.28 in the previous year[3] - Basic earnings per share increased to ¥0.61, reflecting a 56.41% rise from ¥0.39 in the same quarter last year[4] - Total operating revenue for the period reached ¥1,327,973,775.78, a significant increase from ¥854,502,742.45 in the previous period, representing a growth of approximately 55.4%[23] - Net profit for the period was ¥1,049,914,368.08, compared to ¥664,786,735.95 in the previous period, indicating a year-over-year increase of about 58%[23] - Basic earnings per share rose to ¥0.61, up from ¥0.39 in the previous period, reflecting a growth of 56.4%[24] - Operating profit increased to ¥1,286,246,347.19, compared to ¥821,546,213.44 in the previous period, marking a growth of approximately 56.5%[22] - Total comprehensive income for the period was ¥999,193,999.93, compared to ¥719,630,838.93 in the previous period, representing an increase of about 38.9%[24] Cash Flow and Assets - The company's cash flow from operating activities was ¥665,857,256.12, a significant recovery from a negative cash flow of ¥45,114,075.46 in the same period last year[3] - Cash and cash equivalents increased by CNY 66,108.26 million, a change of 289.46% year-on-year, driven by sales growth, improved collections, and recovery of large deposits and financial products[9] - Cash inflow from investment activities amounted to ¥2,851,649,098.28, significantly higher than ¥573,413,952.59 in the previous period[26] - The net increase in cash and cash equivalents was 661,082,633.87, contrasting with a decrease of -348,932,763.25 in the prior period[27] - The ending balance of cash and cash equivalents reached 3,619,597,391.58, compared to 2,551,326,587.08 previously[27] Liabilities and Equity - The total assets at the end of the reporting period were ¥13,635,474,391.00, a 3.60% increase from ¥13,157,665,481.56 at the end of the previous year[4] - The total liabilities increased to CNY 1.878 billion from CNY 2.406 billion at the beginning of the year[21] - The total equity attributable to shareholders reached CNY 11.674 billion, up from CNY 10.693 billion[21] Revenue Breakdown - Domestic business revenue reached CNY 1.878 billion, with the main brand "汤臣倍健" contributing CNY 1.878 billion, up 45.41% year-on-year[15] - Online channel revenue grew by 90.98% year-on-year, accounting for approximately 66.95% of domestic revenue[15] - The overseas business, LSG, generated revenue of CNY 266 million, a year-on-year increase of 58.33%[15] Tax and Expenses - Income tax expenses for the period were CNY 27,805.94 million, an increase of 46.57% year-on-year, mainly due to increased profits during the reporting period[8] - The company’s tax expenses increased to ¥278,059,407.70 from ¥189,716,006.50, reflecting higher profitability[23] Other Financial Metrics - The return on equity (ROE) rose to 9.21%, an increase of 3.10 percentage points compared to 6.11% in the previous year[4] - Accounts receivable increased by 57.55% to ¥520,458,300.00, primarily due to credit extended to customers at the beginning of the year[7] - Non-recurring gains totaled ¥34,867,629.84, primarily from government subsidies and bank financial product income[5] - Asset impairment losses for the period were CNY -407,500, a decrease of 57.44% year-on-year, mainly due to reduced inventory write-down provisions[8] - Other comprehensive income after tax was CNY -50,720.40 million, a change of 192.48% year-on-year, primarily due to fluctuations in foreign currency translation differences[8] Future Outlook - The company plans to continue expanding its product offerings and market presence, focusing on health-related products[15] Audit Status - The first quarter report was not audited[28]